Preferred Label : NCIt Antineoplastic Agent Terminology;
NCIt definition : A terminology subset in NCI Thesaurus (NCIt) containing any agent that has known or
potential antineoplastic activity. The subset includes FDA approved antineoplastic
agents, agents that either are or once were in clinical trial (CT) specifically for
their antineoplastic activity as well as some additional investigational agents that
may have antineoplastic activity. Included in this list are conventional antineoplastic
agents, specific tumor-targeting agents, and cancer immunotherapeutics. Excluded from
this list are: agents that treat cancer-related conditions; cancer diagnostics or
agents used for tumor imaging; agents that treat drug-related adverse effects; any
agent that increases an antineoplastic agent's efficacy or pharmacokinetic profile
but does not have an antineoplastic effect by itself, including immunoadjuvants that
boost efficacy of antineoplastic vaccines; and antineoplastic agents that are conjugated
with a radioisotope and are in CT for efficacy and/or ADME studies.;
NCI Metathesaurus CUI : CL509500;
Origin ID : C128784;
UMLS CUI : C4288628;
Semantic type(s)
- concept_is_in_subset
- subset_includes_concept
